MONDAY, March 9, 2026 -- The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use...

MONDAY, March 9, 2026 -- The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use...

BMJ cohort study links GLP-1 drugs such as semaglutide to lower substance use disorder risk and reduced addiction-related complications in adults...

A new study suggests that a group of medications originally designed to treat diabetes may also help prevent and treat addiction. Researchers at...

A new study suggests that a group of medications originally designed to treat diabetes may also help prevent and treat addiction. Researchers at...

The drugs - known as GLP-1 receptor agonists - were linked to a significantly lower risk of mental health deterioration in people already struggling...

The drugs - known as GLP-1 receptor agonists - were linked to a significantly lower risk of mental health deterioration in people already struggling...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their...